The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)

NCT06960629 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Pseudophakic Bullous Keratopathy
Glaucoma

Interventions

DRUG: Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution
DRUG: Placebo

Sponsor

University Hospital Dubrava